Dc Healthcare Holdings Bhd (XKLS:0283) ROE %: 1.05% (As of Mar. 2026) — 97% Below Median


What is Dc Healthcare Holdings Bhd ROE %?

Dc Healthcare Holdings Bhd XKLS:0283 ROE % is 1.05% as of Mar. 2026, which is 97% below its 10-year median of 30.31. The stock has 8 warning signs investors should review. Among 626 Healthcare Providers & Services companies, Dc Healthcare Holdings Bhd ranks worse than 60.38% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Dc Healthcare Holdings Bhd's annualized net income for the quarter that ended in Mar. 2026 was RM0.47 Mil. Dc Healthcare Holdings Bhd's average Total Stockholders Equity over the quarter that ended in Mar. 2026 was RM45.00 Mil. Therefore, Dc Healthcare Holdings Bhd's annualized ROE % for the quarter that ended in Mar. 2026 was 1.05%.

The historical rank and industry rank for Dc Healthcare Holdings Bhd's ROE % or its related term are showing as below:

XKLS:0283' s ROE % Range Over the Past 10 Years
Min: -36.01   Med: 30.31   Max: 82.96
Current: 2.63

During the past 7 years, Dc Healthcare Holdings Bhd's highest ROE % was 82.96%. The lowest was -36.01%. And the median was 30.31%.

XKLS:0283's ROE % is ranked worse than
60.38% of 626 companies
in the Healthcare Providers & Services industry
Industry Median: 5.805 vs XKLS:0283: 2.63

Dc Healthcare Holdings Bhd  (XKLS:0283) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=0.472/45.001
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0.472 / 85.452)*(85.452 / 113.25)*(113.25 / 45.001)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.55 %*0.7545*2.5166
=ROA %*Equity Multiplier
=0.41 %*2.5166
=1.05 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=0.472/45.001
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (0.472 / 1.292) * (1.292 / 3.408) * (3.408 / 85.452) * (85.452 / 113.25) * (113.25 / 45.001)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.3653 * 0.3791 * 3.99 % * 0.7545 * 2.5166
=1.05 %

Note: The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Dc Healthcare Holdings Bhd ROE % Related Terms


Dc Healthcare Holdings Bhd ROE % Historical Data

* Premium members only.

The historical data trend for Dc Healthcare Holdings Bhd's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dc Healthcare Holdings Bhd ROE % Chart

Dc Healthcare Holdings Bhd Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial 72.18 82.96 6.30 -36.01 0.46

Dc Healthcare Holdings Bhd Quarterly Data
Dec19 Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.57 -9.53 20.88 -1.90 1.05

XKLS:0283 vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Dc Healthcare Holdings Bhd's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dc Healthcare Holdings Bhd ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dc Healthcare Holdings Bhd's ROE % distribution charts can be found below:

* The bar in red indicates where Dc Healthcare Holdings Bhd's ROE % falls into.



Dc Healthcare Holdings Bhd ROE % Calculation

Dc Healthcare Holdings Bhd's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=0.206/( (44.736+44.942)/ 2 )
=0.206/44.839
=0.46 %

Dc Healthcare Holdings Bhd's annualized ROE % for the quarter that ended in Mar. 2026 is calculated as

ROE %=Net Income (Q: Mar. 2026 )/( (Total Stockholders Equity (Q: Dec. 2025 )+Total Stockholders Equity (Q: Mar. 2026 ))/ count )
=0.472/( (44.942+45.06)/ 2 )
=0.472/45.001
=1.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2026) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 1.05% mean?
Dc Healthcare Holdings Bhd (XKLS:0283) has a ROE % of 1.05% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Dc Healthcare Holdings Bhd and its competitors. This is 97% below median its historical median of 30.31. According to the industry distribution chart, Dc Healthcare Holdings Bhd ranks #378 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 60.4%.
Is Dc Healthcare Holdings Bhd's ROE % too high?
Dc Healthcare Holdings Bhd's current ROE % of 1.05% is 97% below median its 10-year median of 30.31. The Healthcare Providers & Services industry median ROE % is 5.81. Dc Healthcare Holdings Bhd's value of 1.05% is 81.9% below this industry median. Based on the distribution chart, Dc Healthcare Holdings Bhd ranks #378 out of 626 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Dc Healthcare Holdings Bhd's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dc Healthcare Holdings Bhd ranks #378 out of 626 companies for ROE %. This places Dc Healthcare Holdings Bhd in the lower half of its industry. The industry median ROE % is 5.81. Dc Healthcare Holdings Bhd's value of 1.05% is 81.9% below this benchmark. While the company's 10-year median is 30.31 vs. the industry median of 5.81, Dc Healthcare Holdings Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dc Healthcare Holdings Bhd's current ROE % of 1.05% is 81.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Dc Healthcare Holdings Bhd and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dc Healthcare Holdings Bhd's current ROE % is 1.05%, which is 97% below median its own 10-year median of 30.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dc Healthcare Holdings Bhd stock overvalued right now?
Based on GuruFocus' analysis, Dc Healthcare Holdings Bhd (XKLS:0283) is currently considered Significantly Undervalued. The stock's GF Value™ is RM0.28, compared to a current price of RM0.10 — trading 64.3% below its estimated fair value. The current ROE % is 1.05%, which is 97% below median its 10-year median of 30.31 and 81.9% below the Healthcare Providers & Services industry median of 5.81. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Dc Healthcare Holdings Bhd (XKLS:0283), the current ROE % is 1.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dc Healthcare Holdings Bhd Business Description

Address Jalan BK5A/2D, A-11-0, A-11-1, A-11-2, Bandar Kinrara, Puchong, SGR, MYS, 47180
Dc Healthcare Holdings Bhd Is an investment holding company. Through its subsidiaries, the company provides Aesthetic Services specializing in Non-Invasive and minimally invasive procedures that includes laser skin rejuvenation, pigmentation and acne treatments, anti-ageing procedures, facial contouring solutions and non-invasive body sculpting. The business activities are categorized into three segments, Aesthetic Services, General Medical Services, and Sale of skincare products. The majority of revenue is derived from the Aesthetic Services segment.